Skip to content

Study of Transcutaneous Electrical Stimulation in gait of people with Parkinson's Disease

Study of Transcutaneous Electrical Stimulation in gait parameters of people with Parkinson's Disease

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12610000922077
Enrollment
17
Registered
2010-10-29
Start date
2010-07-03
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The purpose of the study was to evaluate if the Transcutaneous Electrical Stimulation applied at posterior cervical region segments c3-c5 has an effect in standard motor of Parkinson's disease patients.

Interventions

Before the aplication of stimulation in both groups, we applied a anamnese questionnaire with inclusion criterias of the study and personal informations such age, gender, ocupation, escolarity and time of diagnostic. If the person was able to participate of the study, the Hoehn-Yahr Modified scale was applied for classify the people in different stages of Parkinson's disease. Transcutaneous Electrical Stimulation on posterior cervical region, c3-c5 segments at Tens mode, small electrode of 1 cm

Before the aplication of stimulation in both groups, we applied a anamnese questionnaire with inclusion criterias of the study and personal informations such age, gender, ocupation, escolarity and time of diagnostic. If the person was able to participate of the study, the Hoehn-Yahr Modified scale was applied for classify the people in different stages of Parkinson's disease. Transcutaneous Electrical Stimulation on posterior cervical region, c3-c5 segments at Tens mode, small electrode of 1 cm by 0,5 cm, frequency=250 hz, pulse width=300 ms and intensity regulated at the maximum value possible, but respecting the people's perception. This procedure was a single procedure and had a half hour of duration.

Sponsors

Ronaldo Araujo Abreu
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
52 Years to 77 Years
Healthy volunteers
No

Inclusion criteria

The people were included in the study if they have a physician diagnostic of Parkinson's disease and if they were associated at Instituto Parkinsoniano de Minas Gerais, located at Timoteo city, Minas Gerais, Brazil.

Exclusion criteria

The people were excluded of the study if they have serious cardiorrespiratory or cardiovascular diseases, pathologic joint conditions and incapacity musculoskeletal diseases, another nervous system disease and people classified at estage five of Hoehn Yahr Modified scale.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026